Highly Potent Inhibitors of Quorum Sensing in Staphylococcus aureus Revealed Through a Systematic Synthetic Study of the Group-III Autoinducing Peptide

• Published in: Journal of the American Chemical Society Vol. 135; no. 21; pp. 7869 - 7882
• Main Authors: Tal-Gan, Yftah, Stacy, Danielle M, Foegen, Mary K, Koenig, David W, Blackwell, Helen E
• Format: Journal Article
• Language: English
• Published: WASHINGTON American Chemical Society 29.05.2013; Amer Chemical Soc
• Subjects: Amino Acid Sequence; Bacterial Proteins - chemistry; Chemistry; Chemistry, Multidisciplinary; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Molecular Sequence Data; Peptides - chemistry; Peptides - pharmacology; Physical Sciences; Quorum Sensing - drug effects; Science & Technology; Staphylococcus aureus - drug effects; Staphylococcus aureus - metabolism; Staphylococcus aureus - physiology; GRAM-NEGATIVE BACTERIA; SMALL MOLECULES; ACYLATED HOMOSERINE LACTONES; TOXIC-SHOCK-SYNDROME; MECHANISMS; INTERFERENCE; RECEPTOR-HISTIDINE KINASE; VIRULENCE REGULATION; AGR; COMMUNICATION
• ISSN: 0002-7863; 1520-5126
• DOI: 10.1021/ja3112115

Methods to intercept bacterial quorum sensing (QS) have attracted significant attention as potential anti-infective therapies. Staphylococcus aureus is a major human pathogen that utilizes autoinducing peptide (AIP) signals to mediate QS and thereby regulate virulence. S. aureus strains are categorized into four groups (I–IV) according to their AIP signal and cognate extracellular receptor, AgrC. Each group is associated with a certain disease profile, and S. aureus group-III strains are responsible for toxic shock syndrome and have been underestimated in other infections to date. A limited set of non-native AIP analogs have been shown to inhibit AgrC receptors; such compounds represent promising tools to study QS pathways in S. aureus. We seek to expand this set of chemical probes and report herein the first design, synthesis, and biological testing of AIP-III mimetics. A set of non-native peptides was identified that can inhibit all four of the AgrC receptors (I–IV) with picomolar IC50 values in reporter strains. These analogs also blocked hemolysis by wild-type S. aureus group I–IV strainsa virulence trait under the control of QSat picomolar concentrations. Moreover, four of the lead AgrC inhibitors were capable of attenuating the production of toxic shock syndrome toxin-1 (also under the control of QS) by over 80% at nanomolar concentrations in a wild-type S. aureus group-III strain. These peptides represent, to our knowledge, the most potent synthetic inhibitors of QS in S. aureus known, and constitute new and readily accessible chemical tools for the study of the AgrC system and virulence in this deadly pathogen.